Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 58 days ( 0 % )
Last Price $0.102 0 %
High/ Low $0.102 - $0.102 0%
Chg 7 Days N/A $0.102 $0.102
Chg 30 Days N/A $0.102 $0.102
Chg 12 mos N/A $0.102 $0.102
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos N/A Width: 0 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos N/A - N/A -100.00 % - -100.00 %
Short MA avg 3 mos Sell 0000-00-00 - N/A days
Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short/Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short MA avg 12 mos Sell 0000-00-00 - N/A days
Long MA avg 12 mos Sell 0000-00-00 - N/A days
Short/Long MA avg 12 mos Sell 0000-00-00 - N/A days
Pivot Short Sell 0000-00-00 - N/A days
Bollinger Sell 0000-00-00 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Achaogen

Achaogen, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes antibacterials to treat multi-drug resistant (MDR) gram-negative infections in the United States. The company is principally developing plazomicin, which is in Phase III clinical trial for the treatment of serious bacterial infections due to MDR Enterobacteriaceae, including carbapenem-resistant Enterobacteriaceae. It is also involved in the resear... AKAO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT